The Effect of Time-Restricted Feeding on Anthropometry, Biochemical Parameters, Diet Quality and Eating Behavior

March 4, 2023 updated by: Ayşen Yıldırım, Eastern Mediterranean University

The Effect of Time-Restricted Feeding Intervention on Anthropometric Measurements, Biochemical Parameters, Diet Quality and Eating Behavior in Overweight Female Individuals

The goal of this randomized controlled trial is to to determine the effects of time-restricted feeding intervention on body weight, body composition, biochemical parameters and eating behaviors in overweight female individuals.

The main questions it aims to answer are:

  1. Does time-restricted feeding intervention reduce daily energy intake?
  2. Does time-restricted dietary intervention result in body weight and body fat loss?
  3. Does time-limited nutritional intervention lead to improvements in biochemical parameters?
  4. Does time-restricted feeding intervention improve eating behavior and eating awareness?
  5. Does time-restricted feeding intervention adversely affect diet quality?

The participants in the intervention group will receive a time restricted feeding intervention (first meal at 10:00, last meal at 18:00) for 6 weeks. Meals of the participants are planned as 8 hours of eating and 16 hours of fasting.

Participants in the control group will not receive any dietary intervention.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Following the ethics committee approval, the study will be carried out with the participants who applied to the Famagusta State Hospital Internal Medicine Polyclinic, Specialist Umut Hakligil.

In order to start the study, TR Ministry of Health Nicosia Dr. Necessary permissions were obtained from the Ethics Committee of Burhan Nalbantoğlu State Hospital.

The study is planned to be conducted with 40 female participants, who were not diagnosed with any disease by the physician, aged 19-65, slightly obese, with a BMI of 24.9-29.9 kg/m².

Before being included in the research, participants will be informed about the purpose of the research and the applications to be made during the research.

This information was supported with the valid consent form.

Data Collection Tool: A questionnaire form developed in line with the research purpose was used as a data collection tool in the research.

While collecting data on the individuals participating in the research, the "face-to-face interview method" (mask and distance due to the covid-19 pandemic) by taking necessary precautions such as rules of thumb) will be applied.

Beginning of the Study:

Participants who meet the study criteria and agree to participate in the study will be randomly assigned to the control group or intervention group.

  1. Control group protocol; participants randomized to the control group will not receive any dietary intervention. In this process, how all participants should be asked before starting the study.

    If they are fed, they will be asked to continue in the same way and to maintain their physical activity level.

  2. Intervention group protocol; participants randomized to the intervention group will receive a time-restricted feeding intervention for 6 weeks without energy restriction (adlibitum). Meals of the participants will be planned as 8 hours of eating and 16 hours of fasting.

Meal timing will be set as follows:

  • First meal at 10:00,
  • Last meal at 18:00 in the evening

Participants will be asked not to consume anything other than non-calorie drinks (water, only soda, unsweetened herbal teas, etc.) between 18:00 in the evening and 10:00 in the morning.

Study Type

Interventional

Enrollment (Actual)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Famagusta, Cyprus, 99628
        • Eastern Mediterranean University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

19 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  1. 19-65 age range
  2. Female
  3. BMI: 24.9-29.9 kg/m²
  4. Maintaining general activity and exercise habits during the study period
  5. Stable body weight (<4 kg weight loss or weight gain) for 6 months prior to the start of the study

Exclusion Criteria:

  1. Those with chronic disease (diabetes, hypertension, cardiovascular disease, etc.)
  2. Drug users
  3. Use of supplements that may affect blood lipid profile and blood sugar (omega-3 etc.)
  4. Pregnant women
  5. People in the lactation period
  6. Menopause
  7. Shift workers
  8. Those who follow a Time Restricted (16:8) nutrition program before the study
  9. Those who have followed any particular diet before the study
  10. Those who frequently apply different weight loss diet programs

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Time restricted feeding
The participants in the intervention group will receive a time restricted feeding intervention (first meal at 10:00, last meal at 18:00) for 6 weeks. Meals of the participants are planned as 8 hours of eating and 16 hours of fasting.
In the time-restricted nutrition intervention, the first meal is scheduled at 10:00 and the last meal at 18:00 (ad libitum). Eating for 8 hours and fasting for 16 hours are targeted.
No Intervention: Control
Participants in the control group will not receive any dietary intervention. All participants were asked to continue in the same way they were fed before starting the study throughout the study.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Body Weight
Time Frame: 6 week
Body Weight
6 week
Body Composition
Time Frame: 6 week
total body fluid
6 week
Body Composition
Time Frame: 6 week
total fat mass
6 week
Body Composition
Time Frame: 6 week
muscle mass
6 week
Body Composition
Time Frame: 6 week
fat free mass
6 week
Plasma lipids
Time Frame: 6 week
Total cholesterol
6 week
Plasma lipids
Time Frame: 6 week
Hdl cholesterol
6 week
Plasma lipids
Time Frame: 6 week
Ldl cholesterol
6 week
Plasma lipids
Time Frame: 6 week
Triglyceride
6 week
Blood Pressure
Time Frame: 6 week
Systolic blood pressure
6 week
Blood Pressure
Time Frame: 6 week
Diastolic blood pressure
6 week
Pulse
Time Frame: 6 week
6 week
Biochemistry
Time Frame: 6 week
blood glucose
6 week
Biochemistry
Time Frame: 6 week
fasting insulin
6 week

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: AYŞEN YILDIRIM KIZILDAĞ, PhD, Eastern Mediterranean University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 13, 2021

Primary Completion (Actual)

October 24, 2021

Study Completion (Actual)

June 20, 2022

Study Registration Dates

First Submitted

November 25, 2022

First Submitted That Met QC Criteria

March 4, 2023

First Posted (Estimate)

March 6, 2023

Study Record Updates

Last Update Posted (Estimate)

March 6, 2023

Last Update Submitted That Met QC Criteria

March 4, 2023

Last Verified

February 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • AYildirim

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Study Protocol, Statistical Analysis Plan (SAP), Clinical Study Report (CSR)

IPD Sharing Time Frame

1 year

IPD Sharing Access Criteria

No individual participant data will be shared. Results will be published by the investigators in academic journals.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • CSR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Fasting

Clinical Trials on Time restricted feeding

Subscribe